Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-24 @ 11:41 PM
NCT ID: NCT05811351
Eligibility Criteria: Inclusion Criteria: * Have non-subfoveal (defined as not involving the center point of the fovea) geographic atrophy (GA) secondary to age-related macular degeneration (AMD) with an area that can be measured and measures 2.5 millimeter square (mm\^2) to 17.5 mm\^2 (1- and 7- disc areas respectively), determined by the central reading center (CRC) from screening images of fundus autofluorescence (FAF) and spectral domain optical coherence tomography (SD-OCT) * If GA is multifocal, at least one focal lesion must be greater than or equal to (\>=) 1.25 mm\^2 (0.5- disc area), as assessed by the CRC * GA can be photographed in its entirety by FAF, using a 30- degree image centered on the fovea, as assessed by the CRC * Fellow eye must be present with a best corrected distance visual acuity (BCVA) of counting fingers or better * Man or woman (according to their reproductive organs and functions assigned by chromosomal complement) Exclusion Criteria: * History of transpupillary thermotherapy, photodynamic therapy or external-beam radiation therapy in the region of study eye * Any prior thermal laser in the macular region, regardless of indication * History of retinal detachment (with or without repair) * Active, infectious conjunctivitis, keratitis, scleritis, or endophthalmitis * Any sign of diabetic retinopathy or central serous chorioretinopathy
Healthy Volunteers: False
Sex: ALL
Minimum Age: 60 Years
Study: NCT05811351
Study Brief:
Protocol Section: NCT05811351